Hedge funds cut NFLX, keep big bets on MSFT, AMZN, add NVDA
On Tuesday, Arch Capital Group Ltd. (NASDAQ:ACGL), a $34.47 billion insurance giant trading at 9.27x earnings and 1.66x book value, experienced a change in its stock rating as Jefferies analyst Andrew Andersen downgraded the company from Buy to Hold. The downgrade was accompanied by a revision of the price target to $100 from the previous $106. The adjustment reflects a decreased valuation multiple, moving from 1.7 times book value to 1.6 times. According to InvestingPro data, nine analysts have recently revised their earnings expectations downward for the upcoming period.
Andersen’s comments shed light on the reasons behind the downgrade, pointing to anticipated challenges in the property catastrophe (P-CAT) insurance segment. Despite attractive pricing in the P-CAT market, expectations of a mid-year softening are likely to curb growth and potentially compress returns. The analyst also noted increasing competition in the P-CAT and Specialty lines that may impact growth estimates. While InvestingPro analysis shows the company maintains a "GREAT" financial health score of 3.16, current metrics suggest the stock is trading below its Fair Value.
However, there is a silver lining as the primary Casualty segment is expected to provide some support to Arch Capital’s revenue. Andersen anticipates that the company will adopt a more cautious approach to growth in the second half of 2025 and into 2026, being selective in the face of the evolving market dynamics.
Arch Capital’s new price target implies a modest 6% upside, suggesting that Jefferies sees limited potential for significant stock price appreciation in the near term. The firm’s revised stance on Arch Capital aligns with its expectations of the company’s strategic response to the changing insurance landscape.
In other recent news, Arch Capital Group Ltd. reported first-quarter earnings for 2025 that exceeded expectations, prompting analysts to update their outlooks. Keefe, Bruyette & Woods raised the price target for Arch Capital stock to $113.00, citing the company’s robust performance and strategic management. The firm’s analyst, Meyer Shields, adjusted the estimated earnings per share (EPS) for 2025 to $7.65, reflecting the company’s strong quarterly results. However, the EPS estimate for 2026 was slightly reduced to $9.40 due to anticipated higher core loss and expense ratios. Meanwhile, JMP Securities maintained its Market Outperform rating on Arch Capital, with a $125.00 price target, praising the company as a "best-in-class" entity with a strong operational performance. The firm’s analysts highlighted Arch Capital’s strengths in the property and casualty insurance segments, particularly during current market conditions. Arch Capital’s conservative approach to loss reserve estimations and strategic business decisions were also commended. Keefe analysts reaffirmed their Outperform rating and $113.00 price target, noting significant reserve releases that could benefit the company in the coming years.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.